Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

What the NHS robotic surgery push means for UK medtech

Investment in the sector is splitting three ways: Healthcare AI is surging as the sector’s key growth driver, robotics and lab automation are gaining ground amid staff shortages and cheaper hardware, while medtech has largely stalled, frustrating investors who bought in years ago.

Former 23andMe CEO makes bid with sale reopened

The sale of genetics-led consumer healthcare and biotech company 23andMe has taken an unexpected turn, with bidding reopened and its co-founder and former CEO Anne Wojcicki putting in a nearly $50 million higher offer than the previously confirmed buyer. 

Assura once again rejects PHP in favour of ‘final’ KKR/Stonepeak £1.7bn cash offer

Listed UK healthcare REIT Assura has made a decision between the two parties vying to acquire it: the REIT’s board has agreed to a ‘best and final’ increased cash offer from US PE firms KKR and Stonepeak, which it says it intends to unanimously recommend to shareholders. Primary Healthcare Properties (PHP), Assura's main competitor as the only other UK REIT with a significant primary care portfolio, has responded by sweetening its offer and urging the board to reconsider.

Hims & Hers to acquire ZAVA in global expansion

Hims & Hers health, an American health and wellness platform, has announced its agreement to acquire ZAVA, a UK-based European telehealth platform, as part of a “significant step” in its global expansion.

Find Us